Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Guardian - UK
The Guardian - UK
Business
Julia Kollewe

If AstraZeneca goes to the US, it will be a major blow for London and Labour

Pascal Soriot, chief executive of AstraZeneca, has reportedly discussed moving the company’s listing, and perhaps even its corporate base, to the US.
Pascal Soriot, chief executive of AstraZeneca, has reportedly discussed moving the company’s listing, and perhaps even its corporate base, to the US. Photograph: Sophia Evans/The Observer

Three years ago Pascal Soriot received the ultimate accolade for turning around AstraZeneca – a knighthood for services to UK life sciences and leadership in the global response to the Covid pandemic.

Soriot, who fended off a takeover from the US predator Pfizer in 2014, has grown AstraZeneca into Britain’s most valuable company, thanks to an astute eye for promising medicines and developing one of the first Covid vaccines.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.